FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Shah Chetan 		2. Issuer Name and Ticker or Trading Symbol

AETHLON MEDICAL INC [ AEMD ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      _____ 10% Owner
_____ Officer (give title below)      _____ Other (specify below)
(Last)          (First)          (Middle)

8910 UNIVERSITY CENTER LANE, SUITE 660 		3. Date of Earliest Transaction (MM/DD/YYYY)

10/20/2014
(Street)

SAN DIEGO, CA 92122
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   10/20/2014     A    666667   A $0.093   11920633   D    
Common Stock   10/20/2014     A    333333   A $0.096   12253966   D    
Common Stock   10/20/2014     A    1111111   A $0.108   13365077   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Common Stock Purchase Warrant   $0.093   10/20/2014     D         666667    11/12/2012   11/12/2019   Common Stock   666667     (1) 4835316   D    
Common Stock Purchase Warrant   $0.093   10/20/2014     A      666667       10/20/2014   10/20/2021   Common Stock   666667     (1) 5501983   D    
Common Stock Purchase Warrant   $0.096   10/20/2014     D         333333    2/11/2013   2/11/2020   Common Stock   333333     (1) 5168650   D    
Common Stock Purchase Warrant   $0.096   10/20/2014     A      333333       10/20/2014   10/20/2021   Common Stock   333333     (1) 5501983   D    
Common Stock Purchase Warrant   $0.108   10/20/2014     D         1111111    6/19/2012   6/19/2019   Common Stock   1111111     (1) 4390872   D    
Common Stock Purchase Warrant   $0.108   10/20/2014     A      1111111       10/20/2014   10/20/2021   Common Stock   1111111     (1) 5501983   (2) D    

Explanation of Responses:
( 1)  In addition to the shares of Common Stock issued upon exercise of the warrant, Dr. Shah received a warrant to purchase the same number of shares of Common Stock at the same exercise price as the warrant that was exercised.
( 2)  In addition to the warrants reported on this form as being acquired by him, Dr. Shah also owns warrants to purchase Common Stock as follows: 937,500 shares at $0.125 per share, 534,723 shares at $0.12 per share, 333,333 shares at $0.115 per share, 333,333 shares at $0.121 per share and 1,251,983 shares at $0.132 per share.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Shah Chetan
8910 UNIVERSITY CENTER LANE, SUITE 660
SAN DIEGO, CA 92122 		X



Signatures
/s/ Chetan S. Shah 10/22/2014
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Atlas Copco (PK) (USOTC:ATLRF)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Atlas Copco (PK) Charts.
Atlas Copco (PK) (USOTC:ATLRF)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Atlas Copco (PK) Charts.